Intravitreous ranibizumab as treatment for macular telangiectasia type 2

Archives of Ophthalmology

Volumn 128, Issue 8, 2010, Pages 1075-1078

  Lira, Rodrigo Pessoa Cavalcanti ^a   Silva, Valdir Balarin ^a   Cavalcanti, Tiago Marques ^b   De Souza, Ana Catarina Delgado ^b   Pinto, Alexandre Paashaus Da Costa ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Oftalmo Zona Sul   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LASER COAGULATION; MACULAR TELANGIECTASIA TYPE 2; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TELANGIECTASIA; TREATMENT OUTCOME; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MIDDLE AGED; RETINA; RETINAL DETACHMENT; RETINAL DISEASES; RETINAL VESSELS; TELANGIECTASIS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY;

EID: 77955439082     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.155     Document Type: Article

References (5)

1. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006;124(4): 450-460.
2. Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol. 2007;245(6):783-788. (Pubitemid 46805607)
3. Park DW, Schatz H, McDonald HR, Johnson RN. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology. 1997;104(11):1838-1846. (Pubitemid 28100339)
4. Rishi P, Shroff D, Rishi E. Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol. 2008;246(4):619-621.
5. Kovach JL, Rosenfeld PJ. Bevacizumab (Avastin) therapy for idiopathic macular telangiectasia type II. Retina. 2009;29(1):27-32.